A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females

INTRODUCTION: Hormonal contraceptives are among the most effective forms of reversible contraception, but many other compounds, including some antiretrovirals, have clinically meaningful drug–drug interactions (DDIs) with hormonal contraceptives. Islatravir is a novel human immunodeficiency virus nu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankrom, Wendy, Jackson Rudd, Deanne, Zhang, Saijuan, Fillgrove, Kerry L., Gravesande, Kezia N., Matthews, Randolph P., Brimhall, Darin, Stoch, S. Aubrey, Iwamoto, Marian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692923/
https://www.ncbi.nlm.nih.gov/pubmed/34935295
http://dx.doi.org/10.1002/jia2.25858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692923/
https://www.ncbi.nlm.nih.gov/pubmed/34935295
http://dx.doi.org/10.1002/jia2.25858

Ejemplares similares